Trevi Therapeutics (TRVI) just released updated figures, reporting a third quarter net loss of US$21.45 million and a nine month loss of US$52.44 million, giving investors new context for the recent ...
Source LinkTrevi Therapeutics (TRVI) just released updated figures, reporting a third quarter net loss of US$21.45 million and a nine month loss of US$52.44 million, giving investors new context for the recent ...
Source Link
Comments